The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer
ME Hamaker, AG Vos, CH Smorenburg… - The …, 2012 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the predictive value of geriatric assessments for survival in older cancer patients …
Describe the predictive value of geriatric assessments for survival in older cancer patients …
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 …
E Quoix, G Zalcman, JP Oster, V Westeel, E Pichon… - The Lancet, 2011 - thelancet.com
Background Platinum-based doublet chemotherapy is recommended to treat advanced non-
small-cell lung cancer (NSCLC) in fit, non-elderly adults, but monotherapy is recommended …
small-cell lung cancer (NSCLC) in fit, non-elderly adults, but monotherapy is recommended …
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database
NJ McCleary, JA Meyerhardt, E Green… - Journal of clinical …, 2013 - ascopubs.org
Purpose Prior studies have suggested that patients with stage II/III colon cancer receive
similar benefit from intravenous (IV) fluoropyrimidine adjuvant therapy regardless of age …
similar benefit from intravenous (IV) fluoropyrimidine adjuvant therapy regardless of age …
Anemia, fatigue and aging
L Balducci - Transfusion clinique et biologique, 2010 - Elsevier
Aging is associated with increased incidence and prevalence of both cancer and anemia.
Cancer and aging may conspire in making anemia more frequent and more severe. This …
Cancer and aging may conspire in making anemia more frequent and more severe. This …
[HTML][HTML] Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest …
SI Jalal, HD Riggs, A Melnyk, D Richards, A Agarwala… - Annals of oncology, 2012 - Elsevier
Background Concurrent chemoradiation with etoposide and cisplatin (EP/XRT) is standard
treatment for inoperable stage III locally advanced non-small-cell lung cancer (LA-NSCLC) …
treatment for inoperable stage III locally advanced non-small-cell lung cancer (LA-NSCLC) …
[HTML][HTML] Geriatric oncology: an overview of progresses and challenges
M Extermann - … Research and Treatment: Official Journal of …, 2010 - synapse.koreamed.org
Thanks to the global improvement of health care and living conditions, the world population
is aging. Already, in developed countries half of the cancers occur in patients aged 70 and …
is aging. Already, in developed countries half of the cancers occur in patients aged 70 and …
Basic assessment of the older cancer patient
M Extermann - Current treatment options in oncology, 2011 - Springer
Opinion statement Cancer is a disease of the elderly (median age 67 in the US), and this is a
population with a variable health status. Therefore, treating the older half of the cancer …
population with a variable health status. Therefore, treating the older half of the cancer …
Outcomes of auto-SCT for lymphoma in subjects aged 70 years and over
DJ Andorsky, M Cohen, A Naeim… - Bone marrow …, 2011 - nature.com
The safety and efficacy of auto-SCT for lymphoma in older patients is not well established,
particularly in those⩾ 70 years old. We performed a retrospective analysis comparing 17 …
particularly in those⩾ 70 years old. We performed a retrospective analysis comparing 17 …
Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis
P Ward, JR Hecht, HJ Wang, R Dichmann… - Journal of Geriatric …, 2014 - Elsevier
Objectives Optimal treatment strategies in frail and/or elderly patients with metastatic
colorectal cancer have not been well defined. Using data from a prospective, phase II study …
colorectal cancer have not been well defined. Using data from a prospective, phase II study …
Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer
NJ McCleary, O Odejide, J Szymonifka, D Ryan… - Clinical colorectal …, 2013 - Elsevier
Background Although the safety and efficacy of oxaliplatin-based chemotherapy regimens
for colorectal cancer (CRC) have been demonstrated in adults≥ 75 years of age who are …
for colorectal cancer (CRC) have been demonstrated in adults≥ 75 years of age who are …